Table 3.
Sensitivity, specificity, PPV, and NPV of APRI ≤ 1.5 in combination with different HA cut-off points for the detection of liver fibrosis (stages 0-1) in CHB patients
Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | +LR | -LR | |
APRI < 1. 5 | 35.3 | 81.6 | 41.3 | 82.2 | 1.9 | 0.79 |
+HA < 300 | 45.7 | 86.2 | 44.6 | 83.1 | 3.3 | 0.63 |
+HA < 250 | 42.8 | 83.2 | 42.8 | 81.3 | 2.5 | 0.69 |
+HA < 200 | 38.5 | 80.8 | 40.8 | 80.3 | 2.0 | 0.76 |
+HA < 150 | 31.7 | 78.8 | 37.1 | 77.7 | 1.5 | 0.87 |